The consistent downregulation of these genes in bladder cancer tissues was further validated using independent public datasets, and qRT-PCR experiments confirmed the differential expression of the following six genes: LIMS2, IRAK3, STX2, IL11RA, KCNMB1, and PDLIM7. This evidence concerns the gene STX2 and urinary bladder carcinoma.